J9265: Injection, paclitaxel, 30 mg
J9265 is a HCPCS Level II code for injection, paclitaxel, 30 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2014 and is not valid on new claims.
This code has been terminated
CMS terminated J9265 on December 31, 2014. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9265
- Long descriptor
- Injection, paclitaxel, 30 mg
- Short descriptor
- Paclitaxel injection
- Added
- January 1, 1994
- Terminated
- December 31, 2014
- BETOS
- O1D
- Pricing indicator
- 51: Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service: CMS's own analytic grouping.
Drugs.
Codes adjacent to J9265
HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J9265 is not quite right, the correct code is very often within a few positions of it.
- J9256Injection, nipocalimab-aahu, 3 mg
- J9258Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgterminated
- J9259Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgterminated
- J9260Injection, methotrexate sodium, 50 mg
- J9261Injection, nelarabine, 50 mg
- J9262Injection, omacetaxine mepesuccinate, 0.01 mg
- J9263Injection, oxaliplatin, 0.5 mg
- J9264Injection, paclitaxel protein-bound particles, 1 mg
- J9266Injection, pegaspargase, per single dose vial
- J9267Injection, paclitaxel, 1 mg
- J9268Injection, pentostatin, 10 mg
- J9269Injection, tagraxofusp-erzs, 10 micrograms
- J9270Injection, plicamycin, 2.5 mgterminated
- J9271Injection, pembrolizumab, 1 mg
- J9272Injection, dostarlimab-gxly, 10 mg
- J9273Injection, tisotumab vedotin-tftv, 1 mg